IV Methylprednisolone Administration Guidelines

General Administration Guidelines

High-dose IV methylprednisolone pulse therapy is typically administered as 500-2500 mg total dose for 1-3 consecutive days, according to Praxis Medical Insights 2
After IV pulses are completed, transition to oral prednisone (0.3-0.5 mg/kg/day) for maintenance therapy is typically recommended, as suggested by Praxis Medical Insights 2

For immune thrombocytopenia (ITP), parenteral administration of high-dose methylprednisolone has been used in various regimens, with maintenance therapy using oral corticosteroids often required afterward, as reported in Blood 3
For hyperemesis gravidarum, methylprednisolone is given at 16 mg IV every 8 hours for up to 3 days, followed by tapering over 2 weeks, according to Gastroenterology 4
For severe immune-related adverse events (Grade 4 TTP), methylprednisolone 1 g IV is administered daily for 3 days, with the first dose typically given immediately after plasma exchange, as recommended by the Journal of Clinical Oncology 5

After IV methylprednisolone pulse therapy, patients are typically transitioned to oral prednisone at 1 mg/kg/day (maximum 60 mg/day) with gradual tapering over 3-6 months depending on clinical response, as suggested by Praxis Medical Insights 1
For conditions like pemphigus vulgaris, the oral prednisone dose should be initially reduced by 5-10 mg weekly and more slowly below 20 mg daily, according to Praxis Medical Insights 1
The oral dose should not be reduced to less than 15 mg/day during the first 3 months of treatment in vasculitis, as recommended by Praxis Medical Insights 1